Trends in Cardiovascular Medicine
Volume 15, Issue 6 , Pages 225-229, August 2005

Role of Raf Proteins in Cardiac Hypertrophy and Cardiomyocyte Survival

  • Anthony J. Muslin

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Anthony J. Muslin, Center for Cardiovascular Research, Washington University School of Medicine, 660 South Euclid Avenue, Box 8086, St. Louis, MO 63110, USA. Tel.: (+1)314-747-3525; fax: (+1)314-747-3545.

Center for Cardiovascular Research, Washington University School of Medicine, St Louis, Missouri

Abstract 

Cardiomyocyte survival and growth are regulated by the action of extracellular ligands that activate intracellular signaling cascades. The Raf family of protein serine/threonine kinases plays a critical role in the regulation of cardiomyocyte survival and growth. The three Raf family members, Raf-1, B-Raf, and A-Raf, are highly homologous, and they are all expressed in the heart. Protein kinases of the Raf family phosphorylate and activate the mitogen-activated protein kinase kinases (MKKs, also known as MEKs). MKKs, in turn, are dual-specificity threonine and tyrosine kinases that phosphorylate and activate extracellular signal-regulated kinases (ERKs). ERKs phosphorylate a variety of substrates, including nuclear transcription factors, which regulate cell physiology. Raf proteins also have antiapoptotic activity that is independent of MKK and ERK. In this review, the role of Raf family members in the regulation of cardiomyocyte survival and growth will be discussed.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1050-1738(05)00089-7

doi:10.1016/j.tcm.2005.06.008

Trends in Cardiovascular Medicine
Volume 15, Issue 6 , Pages 225-229, August 2005